Pregnanetriol

A metabolite of 17-ALPHA-HYDROXYPROGESTERONE, normally produced in small quantities by the GONADS and the ADRENAL GLANDS, found in URINE. An elevated urinary pregnanetriol is associated with CONGENITAL ADRENAL HYPERPLASIA with a deficiency of STEROID 21-HYDROXYLASE.

Also Known As:

Networked: 74 relevant articles (1 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Hasegawa, Yukihiro: 2 articles (01/2021 - 01/2008)
2.	Izawa, Masako: 2 articles (01/2021 - 01/2008)
3.	Hamajima, Takashi: 1 article (01/2021)
4.	Itonaga, Tomoyo: 1 article (01/2021)
5.	Avula, Aditya V: 1 article (12/2017)
6.	Bancos, Cristian: 1 article (12/2017)
7.	Bancos, Irina: 1 article (12/2017)
8.	Grebe, Stefan K: 1 article (12/2017)
9.	Hines, Jolaine M: 1 article (12/2017)
10.	Singh, Raman D: 1 article (12/2017)

Related Diseases

1.	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/01/2008 - "Auxological data are the gold standard indexes of the therapeutic conditions in patients with CYP21 deficiency over long-term periods, whereas urinary pregnanetriol (PT) for 24 h has been used as an index for short-term periods. " 01/01/2008 - "The Range of 2.2-3.3 mg/gCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency." 03/01/1976 - "The diagnosis of 21-hydroxylase deficiency was substantiated by the findings of 17-ketosteroid and pregnanetriol excretions of 18.1 and 8.1 mg/24 hours, respectively. " 01/01/2021 - "First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency." 04/01/1999 - "A patient with 21-hydroxylase deficiency, for whom elevated pregnanetriol (P3) levels in urine were not suppressed during treatment with cortisone acetate (65 mg/m2 x day), was examined. "
2.	Cushing Syndrome 05/01/1964 - "URINARY EXCRETION OF PREGNANETRIOL (PREGN-5-ENE-3-BETA, 17-ALPHA, 20-TRIOL) IN CUSHING'S SYNDROME." 07/01/1971 - "[Study of 21-dehydroxysteroids (pregnanetriol and pregnanetriolone) in hyperplasic Cushing's syndrome]." 06/15/1971 - "[Study of 21-deoxysteroids (pregnanetriol and pregnanetriolone) in hyperplasic Cushing's syndrome]."
3.	Hirsutism 04/01/1979 - "Urinary pregnanetriol and delta 5-pregnentriol in women with idiopathic hirsutism." 10/15/1977 - "Urinary pregnanetriol excretion in hirsutism." 11/01/1962 - "[Urinary elimination of pregnanetriol in some cases of hirsutism]." 01/01/1964 - "PREGNANETRIOL STUDIES IN HIRSUTISM AND OTHER ENDOCRINE DISEASES." 03/28/1965 - "[PREGNANETRIOL TESTS IN HIRSUTISM AND OTHER ENDOCRINE DISEASES]."
4.	Endocrine System Diseases (Endocrine Diseases) 01/01/1964 - "PREGNANETRIOL STUDIES IN HIRSUTISM AND OTHER ENDOCRINE DISEASES." 03/28/1965 - "[PREGNANETRIOL TESTS IN HIRSUTISM AND OTHER ENDOCRINE DISEASES]."
5.	Carcinoma (Carcinomatosis) 03/01/1963 - "Further studies on the origin of pregnanetriol in adrenal carcinoma." 08/01/1962 - "Origin of pregnanetriol in a patient with adrenal carcinoma."

Related Drugs and Biologics

1.	pregnanetriolone
2.	Pregnanediol
3.	17-Ketosteroids (17 Ketosteroids)
4.	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)
5.	Hydrocortisone (Cortisol)
6.	Androstenedione (4 Androstene 3,17 dione)
7.	Testosterone (Sustanon)
8.	Adrenocorticotropic Hormone (ACTH)
9.	Androgens
10.	Renin

Related Therapies and Procedures

1.	Therapeutics
2.	Curettage